Product Code: A74410
The surgical dressing market valued for $1,818.05 million in 2021 and is estimated to reach $2,724.45 million by 2031, exhibiting a CAGR of 4.1% from 2022 to 2031.
Surgical dressing is a sterile material used to promote wound healing and is a covering placed over the wound as protection. These dressings are designed to absorb excess fluids, promote healing, and prevent infection by creating a barrier between the wound and the outside environment. Surgical dressings are available in various forms, including gauze pads, bandages, tapes, adhesive strips, and wound covers. These are made up of different materials, such as cotton, polyester, or a combination of other materials. These dressings offer various advantages such as protecting the wound from contamination, reducing the risk of infection, and providing moisture to the wound bed, which increases its adoption in the healthcare sector. In addition, increase in incidences of conditions such as accidental injuries and other injuries requiring surgical interventions is driving the growth of the surgical dressing market.
Surgical dressing offers various advantages in the wound healing process or after a surgical procedure. It is mainly used to protect the wound from mechanical injury, absorbs excess drainage, immobilizes the wound, prevents contamination from bodily discharges, and offers mental and physical comfort for the patient. In addition, surgical dressings are also used to inhibit or kill microorganism with the use of dressings with antiseptics, and antimicrobial properties. Thus, such advantages and applications of surgical dressings lead to an increase its demand in the healthcare sector for wound care management and further boost the growth of the surgical dressing market.
In addition, new product innovation and development by key players in surgical dressing boosts the market growth. Traditional dressings are effective for covering and treating minor wounds, but it is challenging to heal lesions on other sensitive tissues. To overcome this challenge researchers are developing biological film dressings that are expected to optimize the wound repair in sensitive tissues. For instance, a research team from the Technical University of Munich has developed a new type of film dressing that can protect wounds and accelerate wound healing, remove bacteria, and reduce inflammation. The use of mucin molecules in the dressing is an interesting approach, as mucins are known to have anti-inflammatory and antimicrobial properties. Such more product innovations and developments in surgical dressings are anticipated to boost the market growth during the forecast period.
Though, various key factors contribute toward the growth of the market, stringent regulations and approval processes for surgical dressings hinder the growth of the market. These stringent regulations and approval processes are necessary to ensure the safety and effectiveness of surgical dressings, which play a critical role in wound care management and patient recovery. In addition to regulatory approval, surgical dressings must also comply with various industry standards and guidelines. For example, the International Organization for Standardization (ISO) has developed standards for medical products, including surgical dressings, to ensure that it meets the certain quality and safety requirements. This hinders the growth of the market.
However, emerging economies of Asia-Pacific and LAMEA present lucrative opportunities for market players for investments. These regions are characterized by large populations with high levels of economic growth and increasing disposable incomes. As a result, there is a growing demand for healthcare services, including medications and others medical products. Moreover, governments in these regions are increasingly investing in healthcare infrastructure and expanding access to healthcare services, which is further anticipated to augment the surgical dressing market growth.
The surgical dressing market is segmented on the basis of dressing type, product, end user and region. On the basis of dressing type, the market is categorized into primary dressing and secondary dressing. On the basis of product, the market is bifurcated into traditional dressing and advanced dressing. Furthermore, the traditional dressing is segmented into gauze, absorbents, bandages, adhesive tapes and others. On the other hand, advanced dressing segment is further divided into composite dressing, hydrogel dressing, hydrocolloid dressing and others. On the basis of end user, the market is categorized into hospitals, ambulatory surgical centers and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the 3M Company, B. Braun SE, Cardinal Health Inc., Coloplast Group, Convatec Inc., Essity Aktiebolag, Johnson & Johnson, Molnlycke Health Care AB, Organogenesis Inc. and Smith and Nephew Plc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical dressing market analysis from 2021 to 2031 to identify the prevailing surgical dressing market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the surgical dressing market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global surgical dressing market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Dressing Type
- Primary Dressing
- Secondary Dressing
By Product
- Traditional Dressing
- Type
- Gauze
- Absorbents
- Bandages
- Adhesive Tapes
- Others
- Advanced Dressing
- Type
- Composite Dressing
- Hydrogel Dressing
- Hydrocolloid Dressing
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- 3M Company
- Cardinal Health Inc.
- Convatec Group PLC
- Organogenesis Holdings Inc.
- Smith and Nephew plc.
- Essity Aktiebolag AB
- Coloplast
- Johnson and Johnson
- B. Braun SE
- Molnlycke Health Care AB
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter's five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in number of surgeries around the globe
- 3.4.1.2. Increase in number of injuries and accident cases requiring surgical treatments
- 3.4.1.3. Advancements in wound care technology
- 3.4.2. Restraints
- 3.4.2.1. Stringent regulations for manufacturing
- 3.4.3. Opportunities
- 3.4.3.1. Growth opportunity in emerging markets
- 3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: SURGICAL DRESSING MARKET, BY DRESSING TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Primary Dressing
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Secondary Dressing
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
CHAPTER 5: SURGICAL DRESSING MARKET, BY PRODUCT
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Traditional Dressing
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.2.4. Traditional Dressing Surgical Dressing Market by Type
- 5.3. Advanced Dressing
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.3.4. Advanced Dressing Surgical Dressing Market by Type
CHAPTER 6: SURGICAL DRESSING MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Ambulatory Surgical Centers
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
CHAPTER 7: SURGICAL DRESSING MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Dressing Type
- 7.2.3. Market size and forecast, by Product
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Key market trends, growth factors and opportunities
- 7.2.5.1.2. Market size and forecast, by Dressing Type
- 7.2.5.1.3. Market size and forecast, by Product
- 7.2.5.1.4. Market size and forecast, by End User
- 7.2.5.2. Canada
- 7.2.5.2.1. Key market trends, growth factors and opportunities
- 7.2.5.2.2. Market size and forecast, by Dressing Type
- 7.2.5.2.3. Market size and forecast, by Product
- 7.2.5.2.4. Market size and forecast, by End User
- 7.2.5.3. Mexico
- 7.2.5.3.1. Key market trends, growth factors and opportunities
- 7.2.5.3.2. Market size and forecast, by Dressing Type
- 7.2.5.3.3. Market size and forecast, by Product
- 7.2.5.3.4. Market size and forecast, by End User
- 7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Dressing Type
- 7.3.3. Market size and forecast, by Product
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Key market trends, growth factors and opportunities
- 7.3.5.1.2. Market size and forecast, by Dressing Type
- 7.3.5.1.3. Market size and forecast, by Product
- 7.3.5.1.4. Market size and forecast, by End User
- 7.3.5.2. France
- 7.3.5.2.1. Key market trends, growth factors and opportunities
- 7.3.5.2.2. Market size and forecast, by Dressing Type
- 7.3.5.2.3. Market size and forecast, by Product
- 7.3.5.2.4. Market size and forecast, by End User
- 7.3.5.3. UK
- 7.3.5.3.1. Key market trends, growth factors and opportunities
- 7.3.5.3.2. Market size and forecast, by Dressing Type
- 7.3.5.3.3. Market size and forecast, by Product
- 7.3.5.3.4. Market size and forecast, by End User
- 7.3.5.4. Italy
- 7.3.5.4.1. Key market trends, growth factors and opportunities
- 7.3.5.4.2. Market size and forecast, by Dressing Type
- 7.3.5.4.3. Market size and forecast, by Product
- 7.3.5.4.4. Market size and forecast, by End User
- 7.3.5.5. Spain
- 7.3.5.5.1. Key market trends, growth factors and opportunities
- 7.3.5.5.2. Market size and forecast, by Dressing Type
- 7.3.5.5.3. Market size and forecast, by Product
- 7.3.5.5.4. Market size and forecast, by End User
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Key market trends, growth factors and opportunities
- 7.3.5.6.2. Market size and forecast, by Dressing Type
- 7.3.5.6.3. Market size and forecast, by Product
- 7.3.5.6.4. Market size and forecast, by End User
- 7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Dressing Type
- 7.4.3. Market size and forecast, by Product
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Key market trends, growth factors and opportunities
- 7.4.5.1.2. Market size and forecast, by Dressing Type
- 7.4.5.1.3. Market size and forecast, by Product
- 7.4.5.1.4. Market size and forecast, by End User
- 7.4.5.2. China
- 7.4.5.2.1. Key market trends, growth factors and opportunities
- 7.4.5.2.2. Market size and forecast, by Dressing Type
- 7.4.5.2.3. Market size and forecast, by Product
- 7.4.5.2.4. Market size and forecast, by End User
- 7.4.5.3. India
- 7.4.5.3.1. Key market trends, growth factors and opportunities
- 7.4.5.3.2. Market size and forecast, by Dressing Type
- 7.4.5.3.3. Market size and forecast, by Product
- 7.4.5.3.4. Market size and forecast, by End User
- 7.4.5.4. Australia
- 7.4.5.4.1. Key market trends, growth factors and opportunities
- 7.4.5.4.2. Market size and forecast, by Dressing Type
- 7.4.5.4.3. Market size and forecast, by Product
- 7.4.5.4.4. Market size and forecast, by End User
- 7.4.5.5. South Korea
- 7.4.5.5.1. Key market trends, growth factors and opportunities
- 7.4.5.5.2. Market size and forecast, by Dressing Type
- 7.4.5.5.3. Market size and forecast, by Product
- 7.4.5.5.4. Market size and forecast, by End User
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Key market trends, growth factors and opportunities
- 7.4.5.6.2. Market size and forecast, by Dressing Type
- 7.4.5.6.3. Market size and forecast, by Product
- 7.4.5.6.4. Market size and forecast, by End User
- 7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Dressing Type
- 7.5.3. Market size and forecast, by Product
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Key market trends, growth factors and opportunities
- 7.5.5.1.2. Market size and forecast, by Dressing Type
- 7.5.5.1.3. Market size and forecast, by Product
- 7.5.5.1.4. Market size and forecast, by End User
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Key market trends, growth factors and opportunities
- 7.5.5.2.2. Market size and forecast, by Dressing Type
- 7.5.5.2.3. Market size and forecast, by Product
- 7.5.5.2.4. Market size and forecast, by End User
- 7.5.5.3. South Africa
- 7.5.5.3.1. Key market trends, growth factors and opportunities
- 7.5.5.3.2. Market size and forecast, by Dressing Type
- 7.5.5.3.3. Market size and forecast, by Product
- 7.5.5.3.4. Market size and forecast, by End User
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Key market trends, growth factors and opportunities
- 7.5.5.4.2. Market size and forecast, by Dressing Type
- 7.5.5.4.3. Market size and forecast, by Product
- 7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
- 9.1. 3M Company
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
- 9.2. B. Braun SE
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.3. Cardinal Health Inc.
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
- 9.4. Coloplast
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
- 9.5. Convatec Group PLC
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.5.7. Key strategic moves and developments
- 9.6. Essity Aktiebolag AB
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
- 9.7. Molnlycke Health Care AB
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.7.7. Key strategic moves and developments
- 9.8. Organogenesis Holdings Inc.
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
- 9.8.7. Key strategic moves and developments
- 9.9. Smith and Nephew plc.
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
- 9.10. Johnson and Johnson
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments